Pl. Golden et Gm. Pollack, RATIONALE FOR INFLUX ENHANCEMENT VERSUS EFFLUX BLOCKADE TO INCREASE DRUG EXPOSURE TO THE BRAIN, Biopharmaceutics & drug disposition, 19(4), 1998, pp. 263-272
Various methods of optimizing brain exposure to polar compounds have b
een examined. However, direct comparisons of the potential efficacy of
these methods have not been forthcoming. The present study utilized a
mathematical approach to compare the efficacy of two pharmacologic me
thods of improving brain drug distribution: uptake enhancement and eff
lux blockade. In the present simulation study, the pharmacokinetics of
a hypothetical marker and modifier were described by differential equ
ations. The relationship between modifier effect on marker uptake into
, or efflux from, the brain and modifier concentration in serum (uptak
e enhancement) or brain tissue (efflux blockade) was described by the
Hill equation. Uptake enhancement increased both the rate and extent o
f marker penetration into the brain. Efflux blockade resulted in delay
ed attainment of maximum marker concentration, and prolonged marker re
sidence, in brain tissue. Under all conditions and doses examined, upt
ake enhancement was more effective than efflux blockade in maximizing
brain tissue exposure to the marker. Although development of agents th
at enhance uptake of polar compounds may be Limited by the potential d
eleterious effects of blood-brain barrier disruption, use of this appr
oach in theory could represent a significant advancement in the treatm
ent of brain disorders. (C) 1998 John Wiley & Sons, Ltd.